Crescent Sterling’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Sell |
15,636
-1,945
| -11% | -$361K | 3.25% | 10 |
|
|
2025
Q1 | $3.68M | Sell |
17,581
-2,111
| -11% | -$442K | 3.78% | 7 |
|
|
2024
Q4 | $3.5M | Sell |
19,692
-830
| -4% | -$147K | 3.59% | 7 |
|
|
2024
Q3 | $4.05M | Sell |
20,522
-724
| -3% | -$143K | 3.86% | 4 |
|
|
2024
Q2 | $3.64M | Sell |
21,246
-418
| -2% | -$71.7K | 3.49% | 7 |
|
|
2024
Q1 | $3.95M | Sell |
21,664
-365
| -2% | -$66.5K | 3.6% | 7 |
|
|
2023
Q4 | $3.41M | Sell |
22,029
-37
| -0.2% | -$5.73K | 3.41% | 9 |
|
|
2023
Q3 | $3.29M | Sell |
22,066
-965
| -4% | -$144K | 3.48% | 8 |
|
|
2023
Q2 | $3.1M | Buy |
23,031
+89
| +0.4% | +$12K | 2.94% | 10 |
|
|
2023
Q1 | $3.66M | Buy |
22,942
+1,371
| +6% | +$218K | 3.55% | 9 |
|
|
2022
Q4 | $3.49M | Buy |
+21,571
| New | +$3.49M | 3.74% | 9 |
|